AASLD: Platelet Booster Aids HCV Therapy (CME/CE)

SAN FRANCISCO (MedPage Today) — Patients with chronic hepatitis C virus infection and thrombocytopenia had significant improvement in virologic response when pegylated interferon alpha 2a was given with eltrombopag, results of a randomized trial showed.

Post a Comment

Comments are closed.